Overview Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma Status: Recruiting Trial end date: 2022-06-17 Target enrollment: Participant gender: Summary This study is a double-blind, parallel-group, randomized study of active drug vs placebo in asthma. Phase: Phase 1 Details Lead Sponsor: Biohaven Pharmaceuticals, Inc.